AML 0 3 0 3 B-cancer
and 4 7 4 7 O
ALL 8 11 8 11 B-cancer
in 12 14 12 14 O
1st 15 18 15 18 O
complete 19 27 19 27 O
remission 28 37 28 37 O
( 38 39 38 39 O
CR1 39 42 39 42 O
) 42 43 42 43 O

AML 0 3 44 47 B-cancer
and 4 7 48 51 O
ALL 8 11 52 55 B-cancer
in 12 14 56 58 O
1st 15 18 59 62 O
or 19 21 63 65 O
2nd 22 25 66 69 O
relapse 26 33 70 77 O
or 34 36 78 80 O
primary 37 44 81 88 O
refractory 45 55 89 99 O

AML 0 3 100 103 B-cancer
and 4 7 104 107 O
ALL 8 11 108 111 B-cancer
in 12 14 112 114 O
2nd 15 18 115 118 O
or 19 21 119 121 O
subsequent 22 32 122 132 O
CR 33 35 133 135 B-treatment

Administration 0 14 136 150 O
of 15 17 151 153 O
G 18 19 154 155 B-treatment
- 19 20 155 156 I-treatment
CSF 20 23 156 159 I-treatment
after 24 29 160 165 O
haploidentical 30 44 166 180 B-treatment
HCT 45 48 181 184 I-treatment

Age 0 3 185 188 B-age
≥ 4 5 189 190 O
18 6 8 191 193 B-lower_bound
years 9 14 194 199 I-lower_bound

Bilirubin 0 9 200 209 B-clinical_variable
< 10 11 210 211 O
1.5 12 15 212 215 B-upper_bound
x 16 17 216 217 I-upper_bound
ULN 18 21 218 221 I-upper_bound
; 21 22 221 222 O
transaminases 23 36 223 236 B-clinical_variable
< 37 38 237 238 O
3 39 40 239 240 B-upper_bound
x 41 42 241 242 I-upper_bound
ULN 43 46 243 246 I-upper_bound

Contraindication 0 16 247 263 O
to 17 19 264 266 O
haploidentical 20 34 267 281 B-treatment
HCT 35 38 282 285 I-treatment
as 39 41 286 288 O
defined 42 49 289 296 O
by 50 52 297 299 O
the 53 56 300 303 O
Investigator 57 69 304 316 O

DLCO 0 4 317 321 B-clinical_variable
> 5 6 322 323 O
50 7 9 324 326 B-lower_bound
% 9 10 326 327 I-lower_bound

Family 0 6 328 334 O
donor 7 12 335 340 O
with 13 17 341 345 O
patient 18 25 346 353 O
- 25 26 353 354 O
donor 26 31 354 359 O
number 32 38 360 366 O
of 39 41 367 369 O
HLA 42 45 370 373 B-clinical_variable
mismatches 46 56 374 384 I-clinical_variable
≥ 57 58 385 386 O
2 59 60 387 388 B-lower_bound
( 61 62 389 390 O
full 62 66 390 394 O
haploidentical 67 81 395 409 O
) 81 82 409 410 O

GvHD 0 4 411 415 B-chronic_disease
requiring 5 14 416 425 O
systemic 15 23 426 434 O
immunosuppressive 24 41 435 452 B-treatment
therapy 42 49 453 460 I-treatment

Infections 0 10 461 471 B-chronic_disease
requiring 11 20 472 481 O
administration 21 35 482 496 O
of 36 38 497 499 O
ganciclovir 39 50 500 511 B-treatment

Left 0 4 512 516 B-clinical_variable
ventricular 5 16 517 528 I-clinical_variable
ejection 17 25 529 537 I-clinical_variable
fraction 26 34 538 546 I-clinical_variable
> 35 36 547 548 O
45 37 39 549 551 B-lower_bound
% 39 40 551 552 I-lower_bound

Ongoing 0 7 553 560 O
systemic 8 16 561 569 B-treatment
immunosuppressive 17 34 570 587 I-treatment
therapy 35 42 588 595 I-treatment
after 43 48 596 601 O
haploidentical 49 63 602 616 B-treatment
HCT 64 67 617 620 I-treatment

PS 0 2 621 623 B-clinical_variable
ECOG 3 7 624 628 I-clinical_variable
< 8 9 629 630 O
2 10 11 631 632 B-upper_bound

Patients 0 8 633 641 O
with 9 13 642 646 O
active 14 20 647 653 O
CNS 21 24 654 657 B-chronic_disease
disease 25 32 658 665 I-chronic_disease

Pregnant 0 8 666 674 B-pregnancy

QTc 0 3 675 678 B-clinical_variable
interval 4 12 679 687 I-clinical_variable
< 13 14 688 689 O
450 15 18 690 693 B-upper_bound
ms 19 21 694 696 I-upper_bound

Serum 0 5 697 702 B-clinical_variable
creatinine 6 16 703 713 I-clinical_variable
< 17 18 714 715 O
1.5 19 22 716 719 B-upper_bound
x 23 24 720 721 I-upper_bound
ULN 25 28 722 725 I-upper_bound

Stable 0 6 726 732 O
clinical 7 15 733 741 O
conditions 16 26 742 752 O
and 27 30 753 756 O
life 31 35 757 761 B-clinical_variable
expectancy 36 46 762 772 I-clinical_variable
> 47 48 773 774 O
3 49 50 775 776 B-lower_bound
months 51 57 777 783 I-lower_bound

family 0 6 784 790 O
donors 7 13 791 797 O
sharing 14 21 798 805 O
one 22 25 806 809 O
HLA 26 29 810 813 B-clinical_variable
- 29 30 813 814 I-clinical_variable
haplotype 30 39 814 823 I-clinical_variable
with 40 44 824 828 O
the 45 48 829 832 O
patient 49 56 833 840 O

secondary 0 9 841 850 B-cancer
AML 10 13 851 854 I-cancer
in 14 16 855 857 O
CR 17 19 858 860 O

valganciclovir 0 14 861 875 B-treatment
at 15 17 876 878 O
the 18 21 879 882 O
time 22 26 883 887 O
of 27 29 888 890 O
infusion 30 38 891 899 B-treatment

